MARS<sup>®</sup>: a futile tool in centres without active liver transplant support

Chun‐Tao Wai, Seng Gee Lim, Myot‐Oo Aung, Yin-Mei Lee, D.S. Sutedja, Yock‐Young Dan, Marion Aw, Seng‐Hock Quak, Margaret K. Lee, M. Da Costa,

Liver International · 2006 · 40 citations · 8 references

Abstract

In this non-randomized study, survival after MARS was related to the availability of transplant, and in patients where living or deceased donor transplant was unavailable, MARS was of little benefit. Randomized-controlled trials on MARS((R)) are urgently needed to clarify its clinical utility.

References

8